{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:05:34Z","timestamp":1793433934833,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007846","name":"Yunnan Province Department of Education","doi-asserted-by":"publisher","award":["2020J0204"],"award-info":[{"award-number":["2020J0204"]}],"id":[{"id":"10.13039\/501100007846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC0907902"],"award-info":[{"award-number":["2017YFC0907902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2020YFA0112300"],"award-info":[{"award-number":["2020YFA0112300"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["2019FB112"],"award-info":[{"award-number":["2019FB112"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["2019HC005"],"award-info":[{"award-number":["2019HC005"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202001AW070018"],"award-info":[{"award-number":["202001AW070018"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202001AY070001-238"],"award-info":[{"award-number":["202001AY070001-238"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771516"],"award-info":[{"award-number":["31771516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802671"],"award-info":[{"award-number":["81802671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830087"],"award-info":[{"award-number":["81830087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872414"],"award-info":[{"award-number":["81872414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetics and Genomics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jgg.2021.02.011","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T20:43:35Z","timestamp":1617050615000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["EphA2: A promising therapeutic target in breast cancer"],"prefix":"10.1016","volume":"48","author":[{"given":"Ping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceshi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgg.2021.02.011_bib1","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1200\/jco.2005.23.16_suppl.9583","article-title":"Overexpression of EphA2 gene in invasive human breast cancer and its association with hormone receptor status","volume":"23","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jgg.2021.02.011_bib2","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1002\/j.1460-2075.1994.tb06685.x","article-title":"Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors","volume":"13","author":"Beckmann","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.jgg.2021.02.011_bib3","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1096\/fj.05-4038fje","article-title":"Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression","volume":"19","author":"Brantley-Sieders","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jgg.2021.02.011_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024426","article-title":"Eph\/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome","volume":"6","author":"Brantley-Sieders","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jgg.2021.02.011_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2967\/jnumed.115.169839","article-title":"Molecular imaging and quantitation of EphA2 expression in xenograft models with 89Zr-DS-8895a","volume":"57","author":"Burvenich","year":"2016","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.jgg.2021.02.011_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI33154","article-title":"The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling","volume":"118","author":"Brantley-Sieders","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jgg.2021.02.011_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1593\/neo.81578","article-title":"Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors","volume":"11","author":"Bruckheimer","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.jgg.2021.02.011_bib8","first-page":"2840","article-title":"Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior","volume":"62","author":"Carles-Kinch","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mt.2012.210","article-title":"T\u00a0cells redirected to EphA2 for the immunotherapy of glioblastoma","volume":"21","author":"Chow","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jgg.2021.02.011_bib10","first-page":"7907","article-title":"Differential EphA2 epitope display on normal versus malignant cells","volume":"63","author":"Coffman","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12013-012-9365-y","article-title":"Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation","volume":"64","author":"Corsetto","year":"2012","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.jgg.2021.02.011_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.7973638","article-title":"Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity","volume":"266","author":"Davis","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jgg.2021.02.011_bib13","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1074\/jbc.M110.211714","article-title":"Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein","volume":"287","author":"Demont","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijc.2910600119","article-title":"Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis","volume":"60","author":"Easty","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jgg.2021.02.011_bib16","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1074\/jbc.M709934200","article-title":"Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase","volume":"283","author":"Fang","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib17","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/onc.2009.18","article-title":"EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells","volume":"28","author":"Fox","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jgg.2021.02.011_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbrc.2004.04.102","article-title":"Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application","volume":"318","author":"Fox","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jgg.2021.02.011_bib19","first-page":"185","article-title":"A\u00a0paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines","volume":"8","author":"Fox","year":"2011","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.jgg.2021.02.011_bib20","doi-asserted-by":"crossref","first-page":"109668","DOI":"10.1016\/j.cellsig.2020.109668","article-title":"Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains","volume":"73","author":"Gehring","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jgg.2021.02.011_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10549-010-1004-y","article-title":"Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER\/EphA2-positive breast cancer","volume":"127","author":"G\u00f6kmen-Polar","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jgg.2021.02.011_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2015.05.051","article-title":"Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers","volume":"493","author":"Guo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jgg.2021.02.011_bib23","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/0008-5472.CAN-06-2760","article-title":"Selective targeting and potent control of tumor growth using an EphA2\/CD3-Bispecific single-chain antibody construct","volume":"67","author":"Hammond","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib24","doi-asserted-by":"crossref","first-page":"110567","DOI":"10.1016\/j.biopha.2020.110567","article-title":"Role of EFNA1 in tumorigenesis and prospects for cancer therapy","volume":"130","author":"Hao","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jgg.2021.02.011_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/414933a","article-title":"Crystal structure of an Eph receptor-ephrin complex","volume":"414","author":"Himanen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jgg.2021.02.011_bib26","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/15384047.2016.1235663","article-title":"Novel anti-EPHA2 antibody, DS-8895a for cancer treatment","volume":"17","author":"Hasegawa","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jgg.2021.02.011_bib27","first-page":"5830","article-title":"A\u00a0novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein","volume":"10","author":"Holzman","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jgg.2021.02.011_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/abbs\/gmt155","article-title":"Role of plasma membrane lipid composition on cellular homeostasis: learning from cell line models expressing fatty acid desaturases","volume":"46","author":"Jaureguiberry","year":"2014","journal-title":"Acta Biochim. Biophys. Sin. (Sanghai)"},{"key":"10.1016\/j.jgg.2021.02.011_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/1535-7163.MCT-19-0414","article-title":"Synergy between EphA2-ILs-DTXp, a novel EphA2-targeted nanoliposomal taxane, and PD-1 inhibitors in preclinical tumor models","volume":"19","author":"Kamoun","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jgg.2021.02.011_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0962-8924(97)01219-1","article-title":"Integrins and GTPases in tumour cell growth, motility and invasion","volume":"8","author":"Keely","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jgg.2021.02.011_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1593\/neo.05544","article-title":"Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth","volume":"8","author":"Kiewlich","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.jgg.2021.02.011_bib32","doi-asserted-by":"crossref","first-page":"e3134","DOI":"10.1038\/cddis.2017.545","article-title":"Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer","volume":"8","author":"Koshikawa","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jgg.2021.02.011_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrm856","article-title":"Mechanisms and functions of Eph and ephrin signalling","volume":"3","author":"Kullander","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jgg.2021.02.011_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2019.02.019","article-title":"ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2","volume":"449","author":"L\u00e9v\u00eaque","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jgg.2021.02.011_bib35","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/ijc.28451","article-title":"A\u00a0novel human Fab antibody for Trop2 inhibits breast cancer growth in\u00a0vitro and in\u00a0vivo","volume":"134","author":"Lin","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jgg.2021.02.011_bib36","first-page":"6316","article-title":"cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph\/elk family of protein kinases","volume":"10","author":"Lindberg","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jgg.2021.02.011_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00280-018-3535-6","article-title":"YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells","volume":"81","author":"Liu","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jgg.2021.02.011_bib38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2018.12.011","article-title":"S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties","volume":"444","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jgg.2021.02.011_bib39","first-page":"3425","article-title":"EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity","volume":"63","author":"Lu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib40","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1242\/jcs.00625","article-title":"Eph\u2019ective signaling: forward, reverse and crosstalk","volume":"116","author":"Murai","year":"2003","journal-title":"Cell. Sci."},{"key":"10.1016\/j.jgg.2021.02.011_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ccr.2005.07.005","article-title":"A\u00a0conditional feedback loop regulates Ras activity through EphA2","volume":"8","author":"Macrae","year":"2005","journal-title":"Canc. Cell"},{"key":"10.1016\/j.jgg.2021.02.011_bib42","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1172\/JCI127755","article-title":"Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)","volume":"129","author":"Markosyan","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jgg.2021.02.011_bib43","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.91.23.11236","article-title":"Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene","volume":"91","author":"Maroulakou","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jgg.2021.02.011_bib44","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.2174\/0929867323666161101100722","article-title":"The sam domain of EphA2 receptor and its relevance to cancer: a novel challenge for drug discovery?","volume":"23","author":"Mercurio","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrclinonc.2017.123","article-title":"Breast cancer: T-DM1 - an important agent in the history of breast cancer management","volume":"14","author":"Metzger-Filho","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jgg.2021.02.011_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/35000008","article-title":"Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation","volume":"2","author":"Miao","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jgg.2021.02.011_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2009.04.009","article-title":"EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt","volume":"16","author":"Miao","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jgg.2021.02.011_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-019-05482-8","article-title":"Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast","volume":"179","author":"Mitra","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jgg.2021.02.011_bib49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/onc.2013.590","article-title":"EphA2 promotes infiltrative invasion of glioma stem cells in\u00a0vivo through cross-talk with Akt and regulates stem cell properties","volume":"34","author":"Miao","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jgg.2021.02.011_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000164123","article-title":"Overexpression of protein tyrosine kinases in human esophageal cancer","volume":"65","author":"Nemoto","year":"1997","journal-title":"Pathobiology"},{"key":"10.1016\/j.jgg.2021.02.011_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.cgt.7700761","article-title":"Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1","volume":"11","author":"Noblitt","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jgg.2021.02.011_bib52","doi-asserted-by":"crossref","first-page":"19201","DOI":"10.1074\/jbc.270.33.19201","article-title":"Characterization of a novel Src-like adapter protein that associates with the Eck receptor tyrosine kinase","volume":"270","author":"Pandey","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib53","doi-asserted-by":"crossref","first-page":"30154","DOI":"10.1016\/S0021-9258(18)43790-8","article-title":"Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity","volume":"269","author":"Pandey","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib54","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc904","article-title":"c-MYC: more than just a matter of life and death","volume":"2","author":"Pelengaris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jgg.2021.02.011_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042120","article-title":"A\u00a0small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in\u00a0vitro and prostate cancer metastasis in\u00a0vivo","volume":"7","author":"Petty","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jgg.2021.02.011_bib56","doi-asserted-by":"crossref","first-page":"172912","DOI":"10.1016\/j.ejphar.2020.172912","article-title":"A\u00a0new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in\u00a0vitro anti-cancer potency","volume":"870","author":"Rezaie","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jgg.2021.02.011_bib57","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0960-9822(98)70400-2","article-title":"Src-like adaptor protein (Slap) is a negative regulator of mitogenesis","volume":"8","author":"Roche","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jgg.2021.02.011_bib58","first-page":"G824","article-title":"Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function","volume":"273","author":"Rosenberg","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jgg.2021.02.011_bib59","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.21873\/anticanres.12592","article-title":"An agonistic antibody to EPHA2 exhibits antitumor effects on human melanoma cells","volume":"38","author":"Sakamoto","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib60","first-page":"59","article-title":"Claudin-4 controls the receptor tyrosine kinase\u00a0EphA2 pro-oncogenic switch through \u03b2catenin","volume":"12","author":"Shang","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jgg.2021.02.011_bib61","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1021\/acs.jmedchem.7b01837","article-title":"Reduction of circulating cancer cells and metastases in breast-cancer models by a potent EphA2-agonistic peptide-drug conjugate","volume":"61","author":"Salem","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau1207","article-title":"Caught in the \"Akt\": cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF","volume":"11","author":"Shi","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jgg.2021.02.011_bib63","doi-asserted-by":"crossref","first-page":"27271","DOI":"10.1074\/jbc.M115.676866","article-title":"EphA2 receptor unliganded dimers suppress EphA2 pro-tumorigenic signaling","volume":"290","author":"Singh","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbamcr.2016.10.011","article-title":"The SAM domain inhibits EphA2 interactions in the plasma membrane","volume":"1864","author":"Singh","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib65","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1038\/onc.2017.170","article-title":"Targeting EphA2 impairs cell cycle progression and growth of basal-like\/triple-negative breast cancers","volume":"36","author":"Song","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.jgg.2021.02.011_bib66","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/0008-5472.CAN-13-2136","article-title":"JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer","volume":"74","author":"Song","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2004.09.002","article-title":"The role of ephrins and Eph receptors in cancer","volume":"15","author":"Surawska","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jgg.2021.02.011_bib68","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1038\/sj.onc.1201839","article-title":"Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase","volume":"16","author":"Takeda","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.jgg.2021.02.011_bib69","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41388-018-0569-5","article-title":"Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux","volume":"38","author":"Torres-Adorno","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.jgg.2021.02.011_bib70","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/carcin\/bgv087","article-title":"miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene","volume":"36","author":"Tsouko","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jgg.2021.02.011_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/bcr2207","article-title":"Eph receptors in breast cancer: roles in tumor promotion and tumor suppression","volume":"10","author":"Vaught","year":"2008","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib72","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1091\/mbc.e08-04-0378","article-title":"Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase","volume":"20","author":"Vaught","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jgg.2021.02.011_bib73","first-page":"79","article-title":"c-Cbl-dependent EphA2 protein degradation is induced by ligand binding","volume":"1","author":"Walker-Daniels","year":"2002","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T","article-title":"Overexpression of the EphA2 tyrosine kinase in prostate cancer","volume":"41","author":"Walker-Daniels","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.jgg.2021.02.011_bib75","article-title":"Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions","volume":"7","author":"Wang","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jgg.2021.02.011_bib76","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1158\/1541-7786.MCR-08-0244","article-title":"The EphA2 receptor and EphrinA1 ligand in solid tumors: function and therapeutic targeting","volume":"6","author":"Wykosky","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib77","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41422-019-0225-9","article-title":"Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib78","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1074\/jbc.M117.814046","article-title":"Protein C receptor stimulates multiple signaling pathways in breast cancer cells","volume":"293","author":"Wang","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jgg.2021.02.011_bib79","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-020-00944-9","article-title":"Targeting EphA2 in cancer","volume":"13","author":"Xiao","year":"2020","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.jgg.2021.02.011_bib80","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-15-0847","article-title":"The Ephrin-A1\/EPHA2 signaling axis regulates glutamine metabolism in HER2-positive breast cancer","volume":"76","author":"Youngblood","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib81","first-page":"629","article-title":"E-cadherin regulates the function of the EphA2 receptor tyrosine kinase","volume":"10","author":"Zantek","year":"1999","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.jgg.2021.02.011_bib82","first-page":"3640","article-title":"MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer","volume":"7","author":"Zantek","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib83","first-page":"2301","article-title":"EphA2 overexpression causes tumorigenesis of mammary epithelial cells","volume":"61","author":"Zelinski","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgg.2021.02.011_bib84","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jcb.10186","article-title":"Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase","volume":"85","author":"Zelinski","year":"2002","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.jgg.2021.02.011_bib85","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ebiom.2018.05.003","article-title":"Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer","volume":"31","author":"Zhang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jgg.2021.02.011_bib86","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/ncomms8679","article-title":"Crucial roles of RSK in cell\u00a0motility\u00a0by catalyzing serine phosphorylation of EphA2","volume":"6","author":"Zhou","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jgg.2021.02.011_bib87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/0008-5472.CAN-09-1845","article-title":"Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy","volume":"70","author":"Zhuang","year":"2010","journal-title":"Cancer Res."}],"container-title":["Journal of Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S167385272100076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S167385272100076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:33:48Z","timestamp":1761651228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S167385272100076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S167385272100076X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgg.2021.02.011","relation":{},"ISSN":["1673-8527"],"issn-type":[{"value":"1673-8527","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EphA2: A promising therapeutic target in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetics and Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgg.2021.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}